Usually, scientific research excites me. But this paper? It also annoyed me. It explores how statins – the most profitable drug in history, with annual sales exceeding $20 billion – contribute to ...

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.

An increase in sedentary time in childhood raises cholesterol levels by two-thirds as an adult, which can lead to heart ...

A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary heart disease to identify ...

The long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side ...

A drug called bempedoic acid (brand name Nexletol) has been shown to be an effective alternative for lowering cholesterol and reducing heart attack risk, according to a major study published in The ...

For years, statins have been a mainstay of treatment for lowering cholesterol and reducing the risk of complications of heart disease. But, while they’re effective, they can come with intense side ...

A study showed cholesterol-lowering statins do not significantly affect ALS progression or survival. Statin prescriptions for ALS patients should be based on metabolic needs, not ALS diagnosis. More ...

Those who took bempedoic acid once a day had on average a 30.2 mg/dL or 21.3% reduction in low-density lipoprotein (LDL) cholesterol levels over about a three-year period. Elevated LDL levels can lead ...

Adults with high cholesterol taking statins may have a significantly higher risk of developing glaucoma than those not taking the cholesterol-lowering drugs, an observational study of a large research ...